Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2010
09/22/2010CN101842373A 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
09/22/2010CN101842098A Certain nitrogen containing bicyclic chemical entities for treating viral infections
09/22/2010CN101838269A 1,3,8-triaza-spiro[4.5]decane-4-ketone compounds and pharmaceutical application thereof
09/22/2010CN101838268A Pyroquine pesticide and application thereof
09/22/2010CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases
09/21/2010US7799931 Spirocyclic cyclohexane compounds
09/21/2010US7799921 Synthesis of gimatecan by reacting an acetal of 7-formyl-camptothecin with O-t-butylhydroxylamine hydrochloride in a polar protic or aprotic organic solvent
09/21/2010US7799919 Dyes and pigments; use in dye lasers, as labeling groups in analytical processes, as tracers, in scintillation counters, fluorescence solar collectors, liquid crystals, cold light sources, materials testing, as photoconductors, photography, in illumination and display elements, as semiconductors
09/21/2010US7799801 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2010US7799800 Lipid-modified immune response modifiers
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799782 P38 inhibitors and methods of use thereof
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799774 Quinoline derivatives and their use as 5-HT6 ligands
09/21/2010US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans
09/21/2010US7799772 Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
09/21/2010CA2499429C Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
09/21/2010CA2473892C Novel quinoline derivatives
09/21/2010CA2470832C Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/21/2010CA2451573C Technical process for the manufacture of tropenol
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2405002C Antitumoral analogs of et-743
09/21/2010CA2391013C Process and intermediates to a tetrahydro-[1,8]-naphthyridine
09/21/2010CA2333947C Pyrazolopyridine compounds as adenosine a1 antagonist for male sterility
09/16/2010WO2010104973A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010WO2010104945A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010WO2010104406A1 Prodrug forms of kinase inhibitors and their use in therapy
09/16/2010WO2010104047A1 Polycyclic aromatic compound
09/16/2010WO2010103306A1 Benzimidazole derivatives and their use as antivaral agents
09/16/2010WO2010103240A1 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-one derivatives, method for preparing same, and therapeutic uses thereof
09/16/2010WO2010103094A1 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
09/16/2010WO2010102709A1 Materials for organic electroluminescence devices
09/16/2010WO2010077836A3 Pyrrolidine compounds which modulate the cb2 receptor
09/16/2010WO2010057006A9 Azaquinolinone derivatives and uses thereof
09/16/2010US20100234601 Transition metal catalyzed synthesis of 2H-indazoles
09/16/2010US20100234593 Imidazo[4,5-B]Pyridine-7-Carboxamides 704
09/16/2010US20100234418 Compounds and uses thereof
09/16/2010US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
09/16/2010US20100234415 Indole derivatives as crth2 receptor antagonists
09/16/2010US20100234399 Agent for overcoming resistance to anti-cancer agent
09/16/2010US20100234396 Tetrhydropyridoindole Derivatives
09/16/2010US20100234388 Substituted pde5 inhibitors
09/16/2010US20100234387 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals
09/16/2010US20100234384 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
09/16/2010US20100234369 5-cyanothienopyridines for the treatment of tumours
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100233166 Novel ido inhibitors and methods of use
09/16/2010US20100230666 Amine-type polymeric compound, and light-emitting element comprising the same
09/16/2010US20100230660 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
09/16/2010CA2755197A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010CA2755157A1 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-one derivatives, method for preparing same, and therapeutic uses thereof
09/16/2010CA2755061A1 Pyrimidine derivatives as mtor inhibitors
09/16/2010CA2755045A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010CA2754808A1 Prodrug forms of kinase inhibitors and their use in therapy
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2227471A1 Gamma secretase modulators
09/15/2010EP2227470A1 Naphthalene diimide compounds interacting with g-quadruplex regions in dna
09/15/2010EP2227469A1 Mapk/erk kinase inhibitors
09/15/2010EP2079690B1 3-aza-bicyclo[3.1.0]hexane derivatives
09/15/2010EP1805177B9 Pyrrolo[3,2-c]pyridine derivatives and process for the preparation thereof
09/15/2010EP1751156B1 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
09/15/2010EP1611131B1 Pyrazolopyridine derivates
09/15/2010EP1578748B1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
09/15/2010CN101835779A Purine derivatives useful as PI3 kinase inhibitors
09/15/2010CN101835778A Hdac inhibitors
09/15/2010CN101835777A Carbacephem beta-lactam antibiotics
09/15/2010CN101835776A Fused imidazoles for cancer treatment
09/15/2010CN101830935A Solanum cathayanum alkaloid extract and preparation method and application thereof
09/15/2010CN101830921A Novel method for activating 7-halogen of fluoroquinoline-3carboxylic acid and application thereof in forming side chain with secondary amine by using condensation
09/15/2010CN101830902A Method for extracting sparteine
09/15/2010CN101830901A Selenite ion type compound and preparation method and application thereof
09/15/2010CN101830900A Olprinone hydrochloric acid crystal form and preparation method thereof
09/15/2010CN101830899A Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
09/15/2010CN101830898A Preparation method of (S, S)-octahydro-6H-pyrrolo[3, 4-b] pyridine
09/15/2010CN101323782B Perylene electroluminescent material with hole-transporting material and preparation thereof
09/15/2010CN101220030B A kind of multi-ring heterocyclic compound, preparation method and application thereof
09/14/2010US7795447 4-(Acylaminoacetylamino)imidazole derivatives, e.g., methyl 3-(4-{2-[2-(3,5-Difluorophenyl)acetylamino]pentanoylamino}imidazol-1-yl)butyrate; treating neurodegenerative and/or neurological disorders such as Alzheimer's disease and Down's Syndrome
09/14/2010US7795434 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
09/14/2010US7795433 Methods for preparing perylene/perinone pigments
09/14/2010US7795432 reacting tetrachloroperylene-3,4:9,10-tetracarboxylic bisanhydride, diisopropylaniline and butyroaniline in propionic acid to produce N-(2,6-diisopropylphenyl)-N'-[(4-butyric acid)phenyl]-1,6,7,12-tetrachloroperylene-3,4:9,10-tetracarboxylic acid bisimide; thermal, chemical and photophysical stability
09/14/2010US7795431 Terrylene and quaterrylene derivatives
09/14/2010US7795274 6-(Carbocyclylmethyl- or heterocyclylmethyl-substituted)pyrrolo[2,3-c]pyridine derivatives; use alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or mediated conditions or diseases
09/14/2010US7795272 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
09/14/2010US7795264 Tyrosine kinase with immunoglobulin and epidermal growth factor homology domain signaling inhibitors; dysregulated vascular growth disorders
09/14/2010US7795259 pyrrolo[2,3-b]pyrazine derivatives used as enzyme inhibitors for the treatment of cardiovascular disorders, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, bone disorders, cancer and viral diseases
09/14/2010US7794747 Stabilization, homogenizing, sterile filtration, dehydration, reconstitution, ultrafiltration; storage stability; taxanes
09/14/2010CA2552914C Diaza-spiropiperidine derivatives
09/14/2010CA2549431C Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same
09/14/2010CA2434834C 6-substituted pyrido-pyrimidines
09/14/2010CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase
09/10/2010WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism
09/10/2010WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
09/10/2010WO2010101128A1 Amide compound
09/10/2010WO2010100249A1 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
09/10/2010WO2010100215A1 SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE
09/10/2010WO2010100144A1 Fused bicyclic compounds as inhibitors for pi3 kinase
09/10/2010WO2010099740A1 13a-(s) desoxytylophorinine derivatives, preparation method, pharmaceutical compositon and use thereof
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors